To date, very few studies have directly evaluated the alterations of ET-1, CGRP, VCAM-1, ICAM-1 and P-selectin in CVD-susceptible brain regions of a T2DM model. This evidence concerns the gene VCAM1 and type 2 diabetes mellitus.